ClinicalTrials.Veeva

Menu

The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.

I

Institute of Liver and Biliary Sciences, India

Status

Unknown

Conditions

Liver Cirrhoses

Treatments

Other: no intervention

Study type

Observational

Funder types

Other

Identifiers

NCT04345640
ILBS-COVID-01

Details and patient eligibility

About

To address the existing deficiencies in the knowledge regarding liver involvement and spectrum of clinical presentation and the impact of COVID-19 infection in patients of liver disease was planned. The present study will be a hospital based and the cases of confirmed COVID-19 infection will be evaluated in relation to liver involvement irrespective of pre-existing liver disease. The primary objective was to address the clinical presentation, biochemical alteration and outcomes of COVID-19 infection in subjects with chronic hepatitis, cirrhosis in comparison to those having infection in the absence of pre-existing liver disease

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. All patients of COVID-19 positive
  2. Age 18-70 years

Exclusion criteria

  1. No Valid consent

Trial design

1,000 participants in 2 patient groups

Covid-19 with liver disease
Description:
Covid-19 with liver disease
Treatment:
Other: no intervention
Covid-19 without liver disease
Description:
Covid-19 without liver disease
Treatment:
Other: no intervention

Trial contacts and locations

1

Loading...

Central trial contact

Dr Ashok Choudhary, DM

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems